United Kingdom· GB-APID-39130211000001101
Zeposia 0.23mg capsules
A ozanimod product containing ozanimod, registered in United Kingdom by Bristol-Myers Squibb Pharmaceuticals Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Ozanimod is registered in 13 of 19 countries.
Countries holding a registration under ATC L04AE02 (ozanimod), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Ozanimod · ATC L04AE02
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ozanimod costs, country by country.
Normalised to the WHO defined daily dose (0.92 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ozanimod · price per daily dose (0.92 mg)
USD · FX 28 Sept 2026
- CH Switzerland$85.78
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Ozanimod
- Manufacturer
- Bristol-Myers Squibb Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- L04AE02
- ATC class
- Ozanimod
- Defined daily dose
- 0.92 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
852 interactions on record for ozanimod.
Graded by severity as the source publishes them — 578 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ozanimod · interactions on record
852 records
- 578 severe
- 271 moderate
- 3 minor
Most severe, free to view
- FamotidineA02BA03severe
- PapaverineA03AD01severe
- IsomethepteneA03AX10severe
- CisaprideA03FA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ozanimod in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumZeposia 0.23 mg - 0.46 mgBristol-Myers Squibb Pharma
- SwitzerlandZeposia 0.23 mg, HartkapselnBristol-Myers Squibb SA
- SpainZEPOSIA 0,23 MG/0,46 MG CAPSULAS DURASBristol-Myers Squibb Pharma Eeig
- IrelandZeposia 0.23 mg hard capsules Zeposia 0.46 mg hard capsulesBristol-Myers Squibb Pharma EEIG
- IcelandZeposiaBristol-Myers Squibb Pharma EEIG*
- NetherlandsZeposia 0,23 mg capsule, hardBristol-Myers Squibb Pharma EEIG
- NorwayZeposiaBristol-Myers Squibb Pharma EEIG (1)
- SwedenZeposia 0,23 mg + 0,46 mg Kapsel, hårdBristol-Myers Squibb Pharma EEIG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Zeposia
- Liechtenstein · Zeposia
- Norway · Zeposia
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/742db2f5-2830-454f-b658-3cbcbdd9d6cc GET /v1/drugs/742db2f5-2830-454f-b658-3cbcbdd9d6cc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "39130211000001101",
"desc": "Zeposia 0.23mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)",
"form": "Oral capsule",
"vpid": "39149511000001105",
"source": "dmd",
"vtm_id": "871801009",
"strength": "230 microgram",
"substance": "Ozanimod",
"ingredient": "Ozanimod hydrochloride",
"supplier_code": "3145301000001104"
}See everything about ozanimod.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.